Matthew P. Young serves as Executive at Jazz Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Matthew P. Young has executed 60 insider transactions totaling $3.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 29, 2016 involved selling 422 shares valued at $51.3K.
Matthew P. Young currently holds 7,127 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew P. Young has been a net seller of JAZZ stock. They have purchased $0 and sold $3.5M worth of shares.
Matthew P. Young's most recent insider trade was on Feb 29, 2016, when they sold 422 shares at $121.58 per share.
Get notified when new Form 4 filings are submitted
| $125.00 |
| Discretionary |
| Feb 25, 2016 | JAZZ | $0 | Award | 9,000 | $N/A | Discretionary |
| May 12, 2015 | JAZZ | $141.5K | Payment | 801 | $176.60 | Discretionary |
| May 4, 2015 | JAZZ | $206.5K | Payment | 1,127 | $183.23 | Discretionary |
| Feb 27, 2015 | JAZZ | $74.3K | Payment | 437 | $170.09 | Discretionary |
| Feb 26, 2015 | JAZZ | $0 | Award | 7,675 | $N/A | Discretionary |
| Feb 9, 2015 | PRAH | $0 | Award | 3,624 | $N/A | Discretionary |
| May 12, 2014 | JAZZ | $0 | Award | 6,250 | $N/A | Discretionary |
| May 5, 2014 | JAZZ | $160.0K | Payment | 1,127 | $141.98 | Discretionary |